iVascular
Anna M. Hueto is an experienced executive assistant and management professional with a strong background supporting C-level executives in various organizations. Currently serving as the Executive Assistant to the CEO at iVascular since February 2022, Anna previously held the same title at iVascular from 2015 to 2020 and worked as a Personal Assistant to the Founder and CEO at Redarbor. Anna has also contributed significantly to professional organizations such as the International Management Assistants (IMA), where Anna served as National Chairman, and the European Management Assistants (EUMA) as European Association Secretary. Additional roles include Secretary General at SEiEM and Member of the Editorial Board for Executive Secretary Magazine. Anna's educational qualifications include advanced certifications in business management and English literature.
This person is not in any teams
This person is not in any offices
iVascular
1 followers
The purpose of iVascular is to develop innovative advanced medical devices and therapies for the treatment of disorders of the cardiovascular system. Its staff has extensive knowledge of biopolymers, coatings, drug delivery, mechanical engineering, medicine and pharmacy. They bring together recognised experience in the development of medical devices and implants. Thanks to the know-how provided by our scientists and technicians and an appropriate investment in technology, iVascular has implemented a vertical integration project allowing it to develop, innovate and produce cardiovascular devices from basic raw materials (plastics, polymers, metals, etc.) to the final device or implant. iVascular possesses and develops its own technologies, which have made possible the vertical integration of each and every one of the processes involved in developing a device, from the earliest design stages through to final production. In this way we guarantee the highest quality standards in all our products. iVascular has a technology center with more than 1000 m² of clean rooms (ISO 7 and ISO 8) and 250 m² of R&D laboratories equipped with the most comprehensive, advanced instrumentation in the biotechnology field. Through its direct and indirect sales network, iVascular is present in more than 70 countries around the world, and is providing with full range of products for interventional cardiology and endovascular procedures. For more information about iVascular, please, visit www.ivascular.global or If you have any questions or comments, we are ready to help you out by an e-mail to info@ivascular.global